Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tommy Chong's Cannabis Full Spectrum Elixir
- Development stage
- Unknown
- Lead developer
- Hollister Biosciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tommy Chong's Cannabis Full Spectrum Elixir is a branded **full-spectrum cannabis tincture** developed and manufactured by Hollister Biosciences and commercialized in California under a licensing agreement with Tommy Chong. The product is a **small-molecule botanical combination** containing a 1:1 ratio of **delta-9-tetrahydrocannabinol** and **cannabidiol**, with 1000 mg total cannabinoids per bottle consisting of 500 mg THC and 500 mg CBD. As a cannabis extract, its pharmacology is driven primarily by modulation of the endocannabinoid system, with THC acting mainly as a partial agonist at cannabinoid receptors and CBD contributing broader cannabinoid-system and non-cannabinoid signaling effects. It has been marketed as a consumer cannabis product for relief of chronic pain and stress rather than as an FDA-approved prescription pharmaceutical.
- Brand names
- Tommy Chong's Cannabis Full Spectrum Elixir
- Other names
- Tommy Chong's Cannabis Full Spectrum ElixirTommy Chong's Full Spectrum Elixir
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Tommy Chong's Cannabis Full Spectrum Elixir.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tommy Chong's Cannabis Full Spectrum Elixir.